Terms: = Lung cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Clinical Outcome
5 results:
1. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
[TBL] [Abstract] [Full Text] [Related]
2. Acquired long QT syndrome in hospitalized patients.
Yu H; Zhang L; Liu J; Liu Y; Kowey PR; Zhang Y; Chen Y; Wei Y; Gao L; Li H; Du J; Xia Y
Heart Rhythm; 2017 Jul; 14(7):974-978. PubMed ID: 28323171
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.
Jiang W; Bi N; Zhang WJ; Wu LH; Liu LP; Men Y; Wang JB; Liang J; Hui ZG; Zhou ZM; Wang LH
Oncotarget; 2016 Apr; 7(16):22632-8. PubMed ID: 26988918
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer.
Ai T; Wang Z; Zhang M; Zhang L; Wang N; Li W; Song L
Int J Biol Markers; 2012 Jul; 27(2):e132-8. PubMed ID: 22467101
[TBL] [Abstract] [Full Text] [Related]
